 | • レポートコード：GIR-2104Z02146 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、胆管がんのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。胆管がんの種類別市場規模（5-フルオロウラシル、ゲムシタビン、シスプラチン、その他）、用途別市場規模（病院・診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・胆管がんの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、F. Hoffmann-La Roche、Bristol-Myers Squibb、Teva Pharmaceutical、Eli Lilly and Company、Sanofi、Fresenius Kabi、Mylan ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：5-フルオロウラシル、ゲムシタビン、シスプラチン、その他 ・用途別分析2016年-2026年：病院・診療所、その他 ・胆管がんの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・胆管がんのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・胆管がんのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・胆管がんの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・胆管がんの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Bile Duct Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Bile Duct Cancer size is estimated to be USD 202.1 million in 2025 from USD 156.2 million in 2019, with a change XX% between 2019 and 2020. The global Bile Duct Cancer market size is expected to grow at a CAGR of 6.7% for the next five years.
Market segmentation
Bile Duct Cancer market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
5-fluorouracil
Gemcitabine
Cisplatin
Other
Market segment by Application, can be divided into
Hospitals & Clinics
Other
Market segment by players, this report covers
Pfizer
F. Hoffmann-La Roche
Bristol-Myers Squibb
Teva Pharmaceutical
Eli Lilly and Company
Sanofi
Fresenius Kabi
Mylan
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Bile Duct Cancer
1.2 Classification of Bile Duct Cancer by Type
1.2.1 Overview: Global Bile Duct Cancer Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Bile Duct Cancer Revenue Market Share by Type in 2020
1.2.3 5-fluorouracil
1.2.4 Gemcitabine
1.2.5 Cisplatin
1.2.6 Other
1.3 Global Bile Duct Cancer Market by Application
1.3.1 Overview: Global Bile Duct Cancer Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals & Clinics
1.3.3 Other
1.4 Global Bile Duct Cancer Market Size & Forecast
1.5 Global Bile Duct Cancer Market Size and Forecast by Region
1.5.1 Global Bile Duct Cancer Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Bile Duct Cancer Market Size by Region, (2016-2021)
1.5.3 North America Bile Duct Cancer Market Size and Prospect (2016-2026)
1.5.4 Europe Bile Duct Cancer Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Bile Duct Cancer Market Size and Prospect (2016-2026)
1.5.6 South America Bile Duct Cancer Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Bile Duct Cancer Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Bile Duct Cancer Market Drivers
1.6.2 Bile Duct Cancer Market Restraints
1.6.3 Bile Duct Cancer Trends Analysis
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Bile Duct Cancer Product and Solutions
2.1.4 Pfizer Bile Duct Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 F. Hoffmann-La Roche
2.2.1 F. Hoffmann-La Roche Details
2.2.2 F. Hoffmann-La Roche Major Business
2.2.3 F. Hoffmann-La Roche Bile Duct Cancer Product and Solutions
2.2.4 F. Hoffmann-La Roche Bile Duct Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb Bile Duct Cancer Product and Solutions
2.3.4 Bristol-Myers Squibb Bile Duct Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.4 Teva Pharmaceutical
2.4.1 Teva Pharmaceutical Details
2.4.2 Teva Pharmaceutical Major Business
2.4.3 Teva Pharmaceutical Bile Duct Cancer Product and Solutions
2.4.4 Teva Pharmaceutical Bile Duct Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Teva Pharmaceutical Recent Developments and Future Plans
2.5 Eli Lilly and Company
2.5.1 Eli Lilly and Company Details
2.5.2 Eli Lilly and Company Major Business
2.5.3 Eli Lilly and Company Bile Duct Cancer Product and Solutions
2.5.4 Eli Lilly and Company Bile Duct Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Eli Lilly and Company Recent Developments and Future Plans
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Bile Duct Cancer Product and Solutions
2.6.4 Sanofi Bile Duct Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Sanofi Recent Developments and Future Plans
2.7 Fresenius Kabi
2.7.1 Fresenius Kabi Details
2.7.2 Fresenius Kabi Major Business
2.7.3 Fresenius Kabi Bile Duct Cancer Product and Solutions
2.7.4 Fresenius Kabi Bile Duct Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Fresenius Kabi Recent Developments and Future Plans
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Bile Duct Cancer Product and Solutions
2.8.4 Mylan Bile Duct Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Mylan Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Bile Duct Cancer Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Bile Duct Cancer Players Market Share
3.2.2 Top 10 Bile Duct Cancer Players Market Share
3.2.3 Market Competition Trend
3.3 Bile Duct Cancer Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Bile Duct Cancer Revenue and Market Share by Type (2016-2021)
4.2 Global Bile Duct Cancer Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Bile Duct Cancer Revenue Market Share by Application (2016-2021)
5.2 Bile Duct Cancer Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Bile Duct Cancer Revenue by Type (2016-2026)
6.2 North America Bile Duct Cancer Revenue by Application (2016-2026)
6.3 North America Bile Duct Cancer Market Size by Country
6.3.1 North America Bile Duct Cancer Revenue by Country (2016-2026)
6.3.2 United States Bile Duct Cancer Market Size and Forecast (2016-2026)
6.3.3 Canada Bile Duct Cancer Market Size and Forecast (2016-2026)
6.3.4 Mexico Bile Duct Cancer Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Bile Duct Cancer Revenue by Type (2016-2026)
7.2 Europe Bile Duct Cancer Revenue by Application (2016-2026)
7.3 Europe Bile Duct Cancer Market Size by Country
7.3.1 Europe Bile Duct Cancer Revenue by Country (2016-2026)
7.3.2 Germany Bile Duct Cancer Market Size and Forecast (2016-2026)
7.3.3 France Bile Duct Cancer Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Bile Duct Cancer Market Size and Forecast (2016-2026)
7.3.5 Russia Bile Duct Cancer Market Size and Forecast (2016-2026)
7.3.6 Italy Bile Duct Cancer Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Bile Duct Cancer Revenue by Type (2016-2026)
8.2 Asia-Pacific Bile Duct Cancer Revenue by Application (2016-2026)
8.3 Asia-Pacific Bile Duct Cancer Market Size by Region
8.3.1 Asia-Pacific Bile Duct Cancer Revenue by Region (2016-2026)
8.3.2 China Bile Duct Cancer Market Size and Forecast (2016-2026)
8.3.3 Japan Bile Duct Cancer Market Size and Forecast (2016-2026)
8.3.4 South Korea Bile Duct Cancer Market Size and Forecast (2016-2026)
8.3.5 India Bile Duct Cancer Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Bile Duct Cancer Market Size and Forecast (2016-2026)
8.3.7 Australia Bile Duct Cancer Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Bile Duct Cancer Revenue by Type (2016-2026)
9.2 South America Bile Duct Cancer Revenue by Application (2016-2026)
9.3 South America Bile Duct Cancer Market Size by Country
9.3.1 South America Bile Duct Cancer Revenue by Country (2016-2026)
9.3.2 Brazil Bile Duct Cancer Market Size and Forecast (2016-2026)
9.3.3 Argentina Bile Duct Cancer Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Bile Duct Cancer Revenue by Type (2016-2026)
10.2 Middle East & Africa Bile Duct Cancer Revenue by Application (2016-2026)
10.3 Middle East & Africa Bile Duct Cancer Market Size by Country
10.3.1 Middle East & Africa Bile Duct Cancer Revenue by Country (2016-2026)
10.3.2 Turkey Bile Duct Cancer Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Bile Duct Cancer Market Size and Forecast (2016-2026)
10.3.4 UAE Bile Duct Cancer Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Bile Duct Cancer Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Bile Duct Cancer Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Bile Duct Cancer Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Bile Duct Cancer Revenue (USD Million) by Region (2016-2021)
Table 5. Global Bile Duct Cancer Revenue Market Share by Region (2021-2026)
Table 6. Pfizer Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Major Business
Table 8. Pfizer Bile Duct Cancer Product and Solutions
Table 9. Pfizer Bile Duct Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors
Table 11. F. Hoffmann-La Roche Major Business
Table 12. F. Hoffmann-La Roche Bile Duct Cancer Product and Solutions
Table 13. F. Hoffmann-La Roche Bile Duct Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 15. Bristol-Myers Squibb Major Business
Table 16. Bristol-Myers Squibb Bile Duct Cancer Product and Solutions
Table 17. Bristol-Myers Squibb Bile Duct Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Teva Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 19. Teva Pharmaceutical Major Business
Table 20. Teva Pharmaceutical Bile Duct Cancer Product and Solutions
Table 21. Teva Pharmaceutical Bile Duct Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors
Table 23. Eli Lilly and Company Major Business
Table 24. Eli Lilly and Company Bile Duct Cancer Product and Solutions
Table 25. Eli Lilly and Company Bile Duct Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Sanofi Corporate Information, Head Office, and Major Competitors
Table 27. Sanofi Major Business
Table 28. Sanofi Bile Duct Cancer Product and Solutions
Table 29. Sanofi Bile Duct Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Fresenius Kabi Corporate Information, Head Office, and Major Competitors
Table 31. Fresenius Kabi Major Business
Table 32. Fresenius Kabi Bile Duct Cancer Product and Solutions
Table 33. Fresenius Kabi Bile Duct Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Mylan Corporate Information, Head Office, and Major Competitors
Table 35. Mylan Major Business
Table 36. Mylan Bile Duct Cancer Product and Solutions
Table 37. Mylan Bile Duct Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global Bile Duct Cancer Revenue (USD Million) by Players (2019-2021)
Table 39. Global Bile Duct Cancer Revenue Share by Players (2019-2021)
Table 40. Breakdown of Bile Duct Cancer by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Bile Duct Cancer Players Head Office, Products and Services Provided
Table 42. Bile Duct Cancer Mergers & Acquisitions in the Past Five Years
Table 43. Bile Duct Cancer New Entrants and Expansion Plans
Table 44. Global Bile Duct Cancer Revenue (USD Million) by Type (2016-2021)
Table 45. Global Bile Duct Cancer Revenue Share by Type (2016-2021)
Table 46. Global Bile Duct Cancer Revenue Forecast by Type (2021-2026)
Table 47. Global Bile Duct Cancer Revenue by Application (2016-2021)
Table 48. Global Bile Duct Cancer Revenue Forecast by Application (2021-2026)
Table 49. North America Bile Duct Cancer Revenue by Type (2016-2021) & (USD Million)
Table 50. North America Bile Duct Cancer Revenue by Type (2021-2026) & (USD Million)
Table 51. North America Bile Duct Cancer Revenue by Application (2016-2021) & (USD Million)
Table 52. North America Bile Duct Cancer Revenue by Application (2021-2026) & (USD Million)
Table 53. North America Bile Duct Cancer Revenue by Country (2016-2021) & (USD Million)
Table 54. North America Bile Duct Cancer Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe Bile Duct Cancer Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe Bile Duct Cancer Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe Bile Duct Cancer Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe Bile Duct Cancer Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe Bile Duct Cancer Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe Bile Duct Cancer Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific Bile Duct Cancer Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific Bile Duct Cancer Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific Bile Duct Cancer Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific Bile Duct Cancer Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific Bile Duct Cancer Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific Bile Duct Cancer Revenue by Region (2021-2026) & (USD Million)
Table 67. South America Bile Duct Cancer Revenue by Type (2016-2021) & (USD Million)
Table 68. South America Bile Duct Cancer Revenue by Type (2021-2026) & (USD Million)
Table 69. South America Bile Duct Cancer Revenue by Application (2016-2021) & (USD Million)
Table 70. South America Bile Duct Cancer Revenue by Application (2021-2026) & (USD Million)
Table 71. South America Bile Duct Cancer Revenue by Country (2016-2021) & (USD Million)
Table 72. South America Bile Duct Cancer Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa Bile Duct Cancer Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa Bile Duct Cancer Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa Bile Duct Cancer Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa Bile Duct Cancer Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa Bile Duct Cancer Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa Bile Duct Cancer Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Bile Duct Cancer Picture
Figure 2. Global Bile Duct Cancer Revenue Market Share by Type in 2020
Figure 3. 5-fluorouracil
Figure 4. Gemcitabine
Figure 5. Cisplatin
Figure 6. Other
Figure 7. Bile Duct Cancer Revenue Market Share by Application in 2020
Figure 8. Hospitals & Clinics Picture
Figure 9. Other Picture
Figure 10. Global Bile Duct Cancer Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Bile Duct Cancer Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Bile Duct Cancer Revenue Market Share by Region (2016-2026)
Figure 13. Global Bile Duct Cancer Revenue Market Share by Region in 2020
Figure 14. North America Bile Duct Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Bile Duct Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Bile Duct Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Bile Duct Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Bile Duct Cancer Market Drivers
Figure 19. Bile Duct Cancer Market Restraints
Figure 20. Bile Duct Cancer Market Trends
Figure 21. Pfizer Recent Developments and Future Plans
Figure 22. F. Hoffmann-La Roche Recent Developments and Future Plans
Figure 23. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 24. Teva Pharmaceutical Recent Developments and Future Plans
Figure 25. Eli Lilly and Company Recent Developments and Future Plans
Figure 26. Sanofi Recent Developments and Future Plans
Figure 27. Fresenius Kabi Recent Developments and Future Plans
Figure 28. Mylan Recent Developments and Future Plans
Figure 30. Global Bile Duct Cancer Revenue Share by Players in 2020
Figure 31. Bile Duct Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 32. Global Top 3 Players Bile Duct Cancer Revenue Market Share in 2020
Figure 33. Global Top 10 Players Bile Duct Cancer Revenue Market Share in 2020
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 35. Global Bile Duct Cancer Revenue Share by Type in 2020
Figure 36. Global Bile Duct Cancer Market Share Forecast by Type (2021-2026)
Figure 37. Global Bile Duct Cancer Revenue Share by Application in 2020
Figure 38. Global Bile Duct Cancer Market Share Forecast by Application (2021-2026)
Figure 39. North America Bile Duct Cancer Sales Market Share by Type (2016-2026)
Figure 40. North America Bile Duct Cancer Sales Market Share by Application (2016-2026)
Figure 41. North America Bile Duct Cancer Revenue Market Share by Country (2016-2026)
Figure 42. United States Bile Duct Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Bile Duct Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Bile Duct Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Bile Duct Cancer Sales Market Share by Type (2016-2026)
Figure 46. Europe Bile Duct Cancer Sales Market Share by Application (2016-2026)
Figure 47. Europe Bile Duct Cancer Revenue Market Share by Country (2016-2026)
Figure 48. Germany Bile Duct Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Bile Duct Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Bile Duct Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Bile Duct Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Bile Duct Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Bile Duct Cancer Sales Market Share by Type (2016-2026)
Figure 54. Asia-Pacific Bile Duct Cancer Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Bile Duct Cancer Revenue Market Share by Region (2016-2026)
Figure 56. China Bile Duct Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Bile Duct Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South Korea Bile Duct Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Bile Duct Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Bile Duct Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Bile Duct Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Bile Duct Cancer Sales Market Share by Type (2016-2026)
Figure 63. South America Bile Duct Cancer Sales Market Share by Application (2016-2026)
Figure 64. South America Bile Duct Cancer Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Bile Duct Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Bile Duct Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East and Africa Bile Duct Cancer Sales Market Share by Type (2016-2026)
Figure 68. Middle East and Africa Bile Duct Cancer Sales Market Share by Application (2016-2026)
Figure 69. Middle East and Africa Bile Duct Cancer Revenue Market Share by Country (2016-2026)
Figure 70. Turkey Bile Duct Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Saudi Arabia Bile Duct Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. UAE Bile Duct Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source
世界の胆管がん市場規模・現状・予測（2021年-2027年） Bile duct cancer or cholangiocarcinoma is a form of cancer in which epithelial cells are mutated, i.e., they show epithelial differentiation in the bile duct. It is a type of rare neoplasm. Market Analysis and Insights: Global Bile Duct Cancer Market The global Bile Duct Cancer market size is projec…- 世界の胆管がん（胆管細胞がん）治療市場規模・現状・予測（2021年-2027年） Bile duct is a network of tube that connects the liver to the gall bladder. Bile duct carries a fluid called bile which is synthesize in the liver and stored in the gall bladder. The primary function of bile is breakdown of fats during digestion. Bile duct cancer is commonly known as cholangiocarcin…
- 世界の膵臓＆胆管結石管理市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pancreatic and Bile Duct Stone Management Market The global Pancreatic and Bile Duct Stone Management market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in anal…
- 世界のエアダクトクリーニングサービス市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Air Duct Cleaning Service Market The global Air Duct Cleaning Service market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…
- 世界のダクト炉市場 2021：企業別、地域別、種類・用途別 The Duct Furnace market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recen…